Evaluation Of Clinical Periodontal Parameters And Pro-Resolvin Mediators Eicosapentanoic Acid (Epa) And Docosahexaenoic Acid (Dha) In Gingival Crevicular Fluid (Gcf) With Flax Seed Extract Gel As Local Drug Delivery In Treatment Of Stage 2 And Stage 3 Periodontitis Patients: A Randomised Controlled Trial - Not applicable

Jisha S Raj0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月1日

试验速览

暂无简介。

•1. Patients diagnosed with Stage 2 and Stage 3 periodontitis in the age group of 25-60 years with a minimum of a total of 24 natural teeth.
•2. Sites having pocket probing depth (PPD) of =5 mm and clinical attachment loss (CAL) of =3mm in the maxillary teeth.

•1. Patients suffering from any form of systemic diseases.
•2. Patients currently on antibiotic/anti-inflammatory therapy, steroids or hormonal therapy within the past 6 months.
•3. Patients with history of any dental therapy in the past 14 days.
•4. History of allergy in using any oral hygiene products.
•5. Patients with oral abusive habits such as smoking , consumption of alcohol or tobacco or parafunctional habits (like bruxism and grinding of teeth)
•6. Pregnant and lactating patients
•7. Patients on a diet rich in omega fatty acids.

发起方

Jisha S Raj